Niklas Loman

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 578 citations

5-Year Analysis, Breast Oncology, Oncology +10

Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study

Johan Staaf, Dominik Głodzik, Ana Bosch et al. · Nature Medicine · 2019 · 294 citations

Whole-genome Sequencing, Breast Oncology, Oncology +10

The Sweden Cancerome Analysis Network - Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine

Lao H. Saal, Johan Vallon‐Christersson, Jari Häkkinen et al. · Genome Medicine · 2015 · 267 citations · Full text

Clinical Value of RNA Sequencing–Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network—Breast Initiative

Christian Brueffer, Johan Vallon‐Christersson, Dorthe Grabau et al. · JCO Precision Oncology · 2018 · 201 citations · Full text

Identification of New MicroRNAs in Paired Normal and Tumor Breast Tissue Suggests a Dual Role for the <i>ERBB2/Her2</i> Gene

Helena Persson, Anders Kvist, Natalia Rego et al. · Cancer Research · 2011 · 198 citations · Full text

Breast Oncology, Engineering, Tumor Biology +17